Top 50 Biotech Angel Investors in Europe in September 2025
A list of 50 angel investors that invest in Biotech startups based in Europe. We rank investors based on the number of investments they made in Biotech companies from Europe. We update this investor list every month.Top 50 Biotech Angel Investors in Europe in September 2025
Investor | Biotech Europe investments |
---|---|
Jonathan Milner | 32 |
Nadav Rosenberg | 5 |
Stefano Bernardi | 5 |
Milad Alucozai | 4 |
Bernard Majoie | 4 |
Charlie Songhurst | 4 |
Sake Bosch | 4 |
Inaki Berenguer | 3 |
Per Falholt | 3 |
Schnidar Harald | 3 |
Peder Nielsen | 3 |
Andrew Keys | 3 |
Taavet Hinrikus | 3 |
Romain Sautrau | 3 |
Pierre Drion | 3 |
David Helgason | 3 |
Annie Vereecken | 3 |
Jeff Dean | 3 |
DrPano Kroko Churchill | 3 |
Ian Hogarth | 3 |
Bradley Horowitz | 3 |
Darrin Disley | 3 |
Nicholas Francis | 3 |
Jude Gomila | 3 |
Andrea Dusi | 3 |
Juan Knuth | 2 |
Fabio Mondini de Focatiis | 2 |
Tim Dempsey | 2 |
Thomas France | 2 |
Raphaël Varane | 2 |
Giampaolo Cagnin | 2 |
Alexandre Yazdi | 2 |
Paul Forster | 2 |
Nadav Ben-Chanoch | 2 |
André-Jacques Auberton-Hervé | 2 |
Detlev Riesner | 2 |
Thor Bjorgolfsson | 2 |
Jim Mellon | 2 |
Luc Vauterin | 2 |
Chris Mairs | 2 |
Sauli Törmälä | 2 |
Mark Evans | 2 |
Jan Hruska | 2 |
Xavier Niel | 2 |
Vishal Gulati | 2 |
Xavier Niel | 2 |
Bruce Linton | 2 |
Hugh Grant | 2 |
Albert Wenger | 2 |
Sten Tamkivi | 2 |
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Series B
- United Kingdom, United States, Spain
Portfolio highlights
- Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
- 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
- Exciting Instruments — We're on a mission to simplify single-molecule fluorescence spectroscopy and make it accessible to all. Find out more about our company, our products and what makes us different.
Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.
Show more
Investment focus
- Biotechnology, Artificial Intelligence, Software
- Seed, Pre-Seed, Series A
- United Kingdom, France, Israel
Portfolio highlights
- thymia — Making mental health as objectively measurable as physical health.
- Loops — With Loops causal insights you can identify your biggest opportunities to maximize your KPIs... try the Loops way
- Lindus Health — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.
Show more
Investment focus
- Biotechnology, Software, Artificial Intelligence
- Seed, Pre-Seed, Funding Round
- United Kingdom, Italy, France
Portfolio highlights
- Freatic — Building the monetization layer for your alpha
- CaSRevolution — A novel disease-modifying approach against neurodegeneration
- Automated Architecture — A global ecosystem of automated micro-factories, to deliver sustainable, affordable and beautiful architecture to millions of people.
Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Pre-Seed
- United States, Canada, United Kingdom
Portfolio highlights
- Replit — Replit is a simple yet powerful online IDE, Editor, Compiler, Interpreter, and REPL. Code, compile, run, and host in 50+ programming languages.
- Revalia Bio — Revalia Bio develops curative drugs for chronic organ-centered disease.
- Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
Bernard Majoie - President @ Fournier-Majoie
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Seed, Pre-Seed, Series A
- France, Belgium
Portfolio highlights
- reMYND — Driving the development of disease-modifying treatments
- AgenT — AgenT develops the first blood diagnosis to detect Alzheimer's years before the onset of the irreversible symptoms.
- PEP-Therapy — PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology
Charles Songhurst is a founding partner of Katana Capital, a long-short equity hedge fund. He also runs the Songhurst Group, which holds assets in a variety of private companies.Charles ran corporate strategy for Microsoft and focused on partnering and M&A. He was involved in the Yahoo acquisition and commercial deal, and the Skypeacquisition. Before running corporate strategy, Charles was focused on the emergence of Google and the growth of the search industry.Prior, Charles was an analyst at McKinsey & Company in London. Charles received a bachelor’s degree from Oxford University in politics, philosophy, and economics.
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Seed, Pre-Seed, Funding Round
- United Kingdom, United States, Germany
Portfolio highlights
- YieldClub — YieldClub is a mobile app that helps you grow your savings with higher returns than a traditional bank.
- Tracelight — Tracelight is an AI-powered Excel add-in that enhances financial modeling by enabling users to generate formulas from natural language, check for errors, and interact with models using plain English. It helps financial professionals save time, reduce errors, and work more efficiently while maintaining security and data privacy.
- Hyperdrives — Discover Hyperdrives, a deep-tech engineering company providing electric drive systems designed to set a new benchmark for performance-to-cost.
Sake Bosch is a Founder and Managing Partner of Prime Ventures since 1999. Sake brings over 25 years of experience in marketing and sales and venture capital to Prime. Prior to founding Prime in 1999, Sake was a Senior Principal at Holland Venture and was responsible for managing investments in technology companies. Sake was involved in many ofthe Holland Venture technology investments including Applicare Medical Imaging (acquired by GE Medical Systems), BWise (acquired by Nasdaq), SQL Systems (acquired by Datastream) and Freecom (acquired by Mitsubishi Kagaku Media). Before joining Holland Venture in 1994, Sake worked as an Independent Corporate Finance Consultant focusing primarily on early stage companies. Prior to this position Sake was a Sales Executive at Securitas Group. Sake started his career in 1989 as a Strategic Market Analyst at VNU. Sake serves on the board of directors of Civolution, 4C, Dealerdirect, Digital Origin, Greetz, Forcare, SaaSPlaza, SlimPay and Takeaway.com. Previous investments include: 3mensio Medical Imaging (acquired by Esaoto), eBuddy (acquired by Booking.com), Global Collect (acquired by General Atlantic), MarketXS (acquired by Markit), Nedstat (acquired by comScore Inc.), Tridion (acquired by SDL) and Watermark (acquired by Qurius). Sake holds an M.Sc. degree in Business Administration as well as a B.A. degree in Management Science and Industrial Engineering.
Show more
Investment focus
- Software, E-Commerce, Biotechnology
- Seed, Series A, Series B
- The Netherlands, France, Israel
Portfolio highlights
- Faircraft — A sustainable, lab-grown alternative to animal leather.
- FononTech — FononTech is an impulse printing company that produces fine-grained patterns in the micro to millimeter range for electronics.
- Magentiq Eye Ltd — AI assisted colonoscopy by MAGENTIQ EYE set a new standard of , recognized by the gastroenterology community for its superior performance.
Inaki Berenguer is the President and Co-founder at iPronics Programmable Photonics.
Show more
Investment focus
- Financial Services, FinTech, E-Commerce
- Seed, Angel, Pre-Seed
- Spain, United States, United Kingdom
Portfolio highlights
- Goin — Goin is a mobile application to save money easily and take advantage of it without knowing how to invest, through Machine Learning algorithms that allow you to accumulate the user's money through small daily gestures. he three Spanish founders, David, Carlos and Gabriel, were looking for a way to optimize their own money, and decided toconduct an experiment by exchanging their debit cards and thus saving 62% during those two months of rehearsal. This is how Goin emerged, which aims to meet the needs of 100% of Millennials, of which 83% confess that they do not know how to save, making available an easy-to-use tool that enhances their finances and lifestyle. On the one hand, the Barcelona startup allows the user to add money automatically and multiply it without having previous knowledge of investment. Goin uses a simple system that first asks to know the user through questions about their habits and, in this way, they are offered automatic systems and methods of saving. Once the user adds money to the app, they can transfer part or all of it to investment, or to their bank account. Its Smart Saving technology manages to accumulate money with small, everyday gestures, such as rounding a payment.
- Bankflip — Permissioned data technology to collect and process your customers' income, tax, employment & other relevant data & documents in real-time
- Mable (Neurolytic Healthcare) — Neurolytic Healthcare provides personalized medicine for neurological conditions. Neurolytic Healthcare collects and extracts insights from a combination of genetic and biomarker data to enhance diagnosis and help clinicians decide on optimal treatment strategies for neurological conditions.The company delivers digitally and genomically-drivenmedical devices to improve the current treatment of migraine and other neurological disorders, including a diagnostic support tool, pharmacogenetic test, and a mobile app for migraine event prediction.
A passion and vision for chemistry and biotechnology led Per (born 1958) to Novo A/S, where he started his career as a research chemist. He subsequently held several managerial positions developing products for the detergent industry and rose to Director for Application Technology in the company’s new enzyme development division in 1995.Hemoved to Raleigh, N.C., to head the company’s U.S. application technology unit in 1997, returning to Denmark three years later as Corporate Vice President of the Enzyme Development and Application division. In April 2000, Per merged the Research and Development division into the newly formed Enzyme Business R&D.Per assumed his current position following Novozymes’ demerger from Novo Nordisk in 2000. As chief science officer, he has helped Novozymes develop a unique industrial biotechnology platform which delivers solutions to meet customer needs and support growth.Per holds a M.Sc. in Chemical Engineering from Technical University of Denmark (DTU). Committed to promoting education and research within the sciences, he was appointed Honorary Professor at DTU’s Institute for Systems Biology in 2010 and became Chairman of the Board in 2013. He is also Chairman of the Young Scientists association in Denmark.Per’s current external positions also include Chairman, DTU, board member of DHI Group, board member of ARTs Biologics A/S, and member of the Danish Council for Research Policy.
Show more
Investment focus
- Biotechnology, Robotics, Life Science
- Seed, Pre-Seed, Series A
- Denmark
Portfolio highlights
- Reshape Biotech — Fully digital microbiology developed by Reshape Biotech
- Synamics Therapeutics — Synamics Therapeutics uses AI and predictive modeling for precision oncology and improved drug discovery. Our adaptive medicine approach helps prolong drug effectiveness and improves outcomes for patients with intractable cancers. Learn more about Synamics Therapeutics and how we leverage AI for personalized, adaptive cancer therapies.
Entrepreneur, Angel Investor, Scientist and Inventor
Show more
Investment focus
- mHealth, Software, Biopharma
- Seed, Angel, Pre-Seed
- Austria
Portfolio highlights
- SCARLETRED — SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connectsto our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.
Peder Nielsen - Member of the Global Advisors Network @ Global Bio Fund
Show more
Investment focus
- Biotechnology, Machine Learning
- Seed, Funding Round
- United Kingdom
Portfolio highlights
- Bactobio — At Bactobio, our mission is to create a safer and greener world by harvesting valuable metabolites from biological dark matter.
Andrew Keys is the Co-Founder and Managing Partner of Andrew Keys. He previously worked for ConsenSys as a Head of Global Business Development. Andrew Keys attended Loyola University Maryland.
Show more
Investment focus
- Software, Finance, Blockchain
- Seed, Pre-Seed, Series A
- United States, India, Norway
Portfolio highlights
- Stackr Labs — Micro-rollups to scale web3 applications
- Zivoe Finance — Join Zivoe in disrupting predatory high-interest lending.
- Ithaca Finance — Ithaca Finance a cross-chain derivatives trading and settlements protocol, is composed of an on-chain settlement layer with an innovative off-chain matching engine.
Taavet Hinrikus is co-founder and CEO of TransferWise. Prior to starting TransferWise, Taavet was Skype’s director of strategy until 2008, starting as its first-ever employee. One of the World Economic Forum's Tech Pioneers, Taavet is an adviser to Prime Minister of Estonia on the digital agenda. He’s also a mentor and angel investor; hisinvestments include Tweetdeck, Mendeley, OMGPOP, Property Partner, Sunrise, Improbable and Mapillary.
Show more
Investment focus
- FinTech, Software, Financial Services
- Seed, Series A, Series B
- United Kingdom, United States, Estonia
Portfolio highlights
- Meatable — Meatable is a food production company that produces real and guilt-free meat. With one cell, they are revolutionizing the meat industry's impact on climate change and animal welfare. At the same time they increase food security, without compromising the culinary experience of eating tasty, real meat. They aim to satisfy the world'sappetite for meat without harming people, animals, and the planet.It was founded in 2018 and is headquartered in Delft, South Holland, The Netherlands.
- Open Cosmos — Open Cosmos design, build and operate space missions, providing straightforward access to high quality satellite data and insights on a global scale.
- Unearthly Materials — Unearthly Materials is a transformative materials company focused on delivering practical room-temperature superconductors and powering the century of superconductivity.
Romain Sautrau is a Investment Director at Supernova Invest. Romain attended INSEAD.
Show more
Investment focus
- Biotechnology, Agriculture, Video
- Series A, Seed, Pre-Seed
- France, Denmark
Portfolio highlights
- Novolyze — Novolyze is a Food Safety company. They offer solutions to help the food industry manufacture safer food, while ensuring strong compliance with international Food Safety & Quality standards. Their research work mainly focuses on evaluating the inactivation of foodborne pathogens under different kinds of stress (heat, etc.). Based on thisexpertise, they have developed the first range of dried, ready-to-use surrogate bacteria, an innovation that allows the food industry to test the efficacy of microbial kill steps / intervention steps in real-life conditions. At Novolyze, they are at the forefront of Food Safety. Their cross-functional team of experts, mainly composed of food microbiologists and process engineers, is able to assist at multiple stages of a project. Novolyze relies on state-of-the-art infrastructures, installed in a pharmaceutical-grade environment at their R&D Center in Dijon, France.
- Antofenol — Antofénol is a post-harvest biocontrol company that directs and develops its work on the valorization of viticultural waste. Antofénol is an innovative biotechnology start-up providing ecological eco-extraction of plant matter.
- nextProtein — nextProtein is developing a large scale and sustainable insect based source of protein. The bioconversion of fly larvae fed with organic waste generates valuable feed components for fish, livestock and pets.
Pierre Drion - CEO @ Petercam
Show more
Investment focus
- Biotechnology, Health Care, Life Science
- Series A, Series B, Funding Round
- Belgium
Portfolio highlights
- A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
- Santero Therapeutics — This is the homepage of the website
David is a technologist, the founder of Unity Technologies, non-exec director to others, and a restless entrepreneur with a passion for creating feedback loops between innovation and teams and products, applying new and old business models to changing industries, and pushing people to do the very best they can do.David's background is inprogramming, an assortment of university dabbling, creating companies, and helping entrepreneurs. He served as CEO of Unity Technologies since co-founding it in 2003 and until October 2014, with an unflinching vision to democratize game development, and to develop technology and business models for the next phase of the games industry. David Helgason attended the University of Copenhagen.
Show more
Investment focus
- Software, Gaming, Information Technology
- Seed, Series A, Funding Round
- United States, Denmark, Finland
Portfolio highlights
- IXI — Discover adaptive glasses with autofocus lenses that adjust to your viewing needs, providing seamless clarity at any distance.
- Noah — API-first stablecoin payments, enterprise-grade compliance and real-time settlements, powered by stablecoin technology.
- Slope — We handle the lending, underwriting, debt collection and fully pay out to you immediately once the product or service ships.
Annie Vereecken
Show more
Investment focus
- Biotechnology, Medical, Hospital
- Seed, Series A, Funding Round
- Belgium
Portfolio highlights
- Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
- Sensolus — Sensolus provides care-free tracking of your valuable non-powered assets directly from the cloud.Sensolus offers turnkey solutions for wireless, low-power context-aware sensing. Sensolus developed a personal product line of low-power tracker systems called STICKNTRACK.Sensolus is built upon many years of expertise in low-power networks,wireless sensor design, cloud-based sensor management, analytics, and applications.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award.
Show more
Investment focus
- Artificial Intelligence, Information Technology, Software
- Seed, Series A, Pre-Seed
- United States, United Kingdom, Japan
Portfolio highlights
- Laborup — Laborup is solving the labor crisis across the U.S. industrial base. We use AI to transform how manufacturers hire, connecting companies with vetted, skilled workers faster and more efficiently than ever before. By eliminating friction in the hiring process, we help manufacturers fill critical roles, keep production on track, and strengthenAmerica’s workforce.The industrial economy is in crisis. Manufacturers are crippled by labor shortages, struggling to find the skilled workers they need. By 2030, 2.1 million manufacturing jobs will go unfilled, leaving supply chains vulnerable and production stalled.This isn’t just an economic issue—it’s a national security threat. The defense industry, critical infrastructure, and manufacturers that keep America running cannot operate without a reliable workforce. Meanwhile, outdated, expensive hiring models are failing. Companies spend months trying to fill roles, only to face high turnover and costly delays.We believe manufacturers and workers everywhere deserve better.
- Emerald AI — Emerald AI creates a platform that enables AI data centers to adjust power consumption from electricity grids dynamically. This system orchestrates computing loads across data centers to bolster grid reliability. The technology aims to advance AI innovation while ensuring power affordability and electric system stability.
- Parallel Bio — Using the immune system to cure disease. Parallel Bio uses a human immune system in a dish and AI to discover drugs more likely to work in patients.
Pano Kroko is a legendary entrepreneur, Angel, VC and PE investor in innovation towards solving big problems. His investment emphasis is on Life Sciences, Biotech, Therapeutics, Medicine, Internet, Mobile, Communications, Clean Technology, Renewable Energy, and Environmental Finance. We have a quarterly Business Plan competition for placementin our early stage start up accelerator in Seattle Washington. We also run a program in Washington DC, and we have an Innovation Master Class Startup Weekend that runs Ten times a year in Seattle, Beijing, Silicon Valley, and in major Universities around the world.The Accelerator in Seattle & Silicon Valley is called American Angels, and the Accelerator in Washington DC is named H2O and both accept business plans and great ideas with Founders, and Executive teams right now. We would like to see StartUps in all of our areas of focus as well as anything else that is great and promising to solve Big Problems. Parallel to this we also run the CEP - Clean Energy Program incubator in Oxford UK, and the Biotech accelerator for genetics, stem cell applications, genomics, medicine, pharma and telomeres research in Cambridge UK.For our more traditional VC and PE work in the US, the American Venture Company in the US and the Investment Bank Green Capital Inc in the UK and Europe. These are our conduits of support for companies and also the Green Bonds Investments Plc. All of our organizations act as levers of positive change for impact investing, and as corporate environmental investment responsibility -- within the Finance community.In Seattle and in Silicon Valley we run the Accelerator and Early Stage Investment firm AMERICAN ANGELS where we have monthly pitches and demos for new StartUps and we also run a CEO roundtable to help promising Entrepreneurial leaders to succeed.If you or your company is interested in cooperation, presenting, funding, deal syndication or simply for submission of Executive Summaries and Business Plans for early stage angel funding and/or inclusion in the H2O Incubator/Accelerator or the Clean Energy program and the Biotech incubator, please contact us herewith: Mr Ruddy Wallace: envpar [at] gmail.com
Show more
Investment focus
- Health Care, Therapeutics, Biotechnology
- Angel, Series A
- United Kingdom
Portfolio highlights
- Amrit Advanced Biotech — Company working in Genetics, Telomeres health applications, cancer mitigation and lengthening of....
Ian got a master's in machine learning at Cambridge and loves dystopian robot takeover narratives. Seven years ago, Ian realized being a choirboy came with no street cred, so he started DJing hip-hop, funk, drum & bass, and grime. Ian quit his job at Bain & Company, Singapore to start Songkick.
Show more
Investment focus
- Software, E-Commerce, Internet
- Seed, Pre-Seed, Series A
- United Kingdom, United States, Germany
Portfolio highlights
- Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
- Unitary — We detect harmful content with context-aware AI to keep brands and platforms safe online.
- Fabric — One home for your digital world. Your second brain. A file explorer and workspace for the internet age. All your drives, clouds, notes, screenshots, links, and files in one calm, minimal app. No organizing required. Never forget anything again.
Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.
Show more
Investment focus
- Software, Information Technology, Health Care
- Seed, Series A, Series B
- United States, United Kingdom, Germany
Portfolio highlights
- /dev/agents — /dev/agents platform will work on new UI patterns that make it easier to build AI agents in a new cloud-based operating system.
- Catena Labs — Catena is a product studio where we transform complex computing advancements into accessible, practical tools for users and developers. Leveraging AI and web3 technology our aim is to turn innovative ideas into real-world applications that are easy to use.
- OrgOrg — OrgOrg provides internal SaaS tools for organizational productivity suite for the companies
Darrin Disley is the CEO, Director & Investor at Mogrify. He attended University of Cambridge.
Show more
Investment focus
- Biotechnology, Health Care, Big Data
- Seed, Series A, Funding Round
- United Kingdom
Portfolio highlights
- bit.bio — Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. Their mission is coding cells for health. To do so, we apply the principles of computation to biology. Bit.bio's current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. Thishas the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by the human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modeling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious, and driven by a common purpose.
- Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
- Desktop Genetics — Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by thereal-world impact of CRISPR technology.They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.
Nicholas Francis is Co-founder at framebunker
Show more
Investment focus
- SaaS, Robotics, Software
- Seed, Series A
- Denmark, United States
Portfolio highlights
- Waterplan — Waterplan is a SaaS platform for companies to manage water availability in their facilities.
- Reshape Biotech — Fully digital microbiology developed by Reshape Biotech
Jude Gomila is currently CEO and Founder of the startup Golden.
Show more
Investment focus
- Software, Biotechnology, Information Technology
- Seed, Pre-Seed, Angel
- United States, United Kingdom, Canada
Portfolio highlights
- Parcha AI — Parcha is an AI-powered enterprise software that enables businesses to automate their scale compliance and operations.
- HockeyStack — HockeyStack enables marketing teams to drive pipeline efficiently and sales teams to close deals faster with modern attribution, holistic buyer journeys, and account insights.
- Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!
Entrepreneur and investor.
After working in management consulting, in 2006 he created Wish Days, known above all for the Emozione3 gift boxes. In April 2016, he sold the company to the Smartbox group with a millionaire exit. In 2017, together with Cristina Pozzi, already a partner in Wish Days he founded Impactscool.He is advisor of dozens oftechnological initiatives and business angels in 150+ startups focusing on clean tech.He is the author of the book “Come far fallire una startup ed essere fellici” – How to make a startup fail and be happy, published by Bompiani, Bestseller in 2018.
Show more
Investment focus
- Biotechnology, Health Care, Information Technology
- Seed, Pre-Seed, Series A
- Italy, United States, United Kingdom
Portfolio highlights
- Talyn Air — Inspired by two-stage rockets, our innovative eVTOL uses two flight vehicles to transform flight. Fixed-wing performance with VTOL capabilities.
- BillionToOne — We are a team at the forefront of disease detection focused on moving Prenatal Screening and Liquid Biopsy forward.
- CaSRevolution — A novel disease-modifying approach against neurodegeneration
Juan Knuth
Show more
Investment focus
- Health Care, Biotechnology, Digital Media
- Seed, Series A
- Spain
Portfolio highlights
- Devicare — Devicare designs point-of-care medical devices that monitor, diagnose and treat chronic diseases. The company's medical devices are useful in measuring the level of biomarkers in body fluids such as saliva, tears, sweat, sputum, feces, urine or blood, enabling medical professionals to detect and treat various infectious diseases.
Venture Partner, Eurazeo InvestmentInternational Venture Capitalist, Business Angel and SVP with >20 years experience in >20 countries, with a successful track as VC, BA and Entrepreneur in a truly global environment. Fabio is a Venture Partner in Eurazeo Investment, following their acquisition of IDINVEST Partners, a leading Europeanprivate equity firm with >9B€ AUM, focusing on Venture Capital investments in Italy across sectors and in the Smart City sector (Energy, Cleantech, Eco-mobility) worldwide. Fabio is the Founder and CEO of growth Capital, the leading Italian investment banking focusing on advising innovative, fast-growing companies on fund raising and M&A. Fabio is also an active Business Angel, with a personal portfolio of more than 30 startups. a Member of the Investment Committee of Lazio Innova. Previously Fabio has been a Senior Advisor in the European Investment Fund (EIF), leading the joint efforts of EIF and Cassa Depositi e Prestiti (CDP) to establish TT Investment Funds in Italy to develop its ecosystem for Innovation.
Before entering the Private Equity sector, Fabio has lead Soitec Solar Division sale after it has increased its revenues from ~2M€ to >40M€ and achieved the world record of PV Module Efficiency and Solar Cell Efficiency. He had earlier founded and lead RenEn Renewable Energy to a leading renewable energy consulting firm.
Earlier Fabio has been in McKinsey, ENEL and Russell Reynolds. In ENEL, Fabio has been Head of Integration, Head of International Management, Head of HR and Organisation and member of the Board of various international companies. Fabio received his M.S. degree in Civil and Environmental Engineering from M.I.T. and his M.B.A. from INSEAD. He is fluent in English, Italian, French and Spanish.
Show more
Investment focus
- E-Commerce, Retail, Information Technology
- Seed, Pre-Seed, Equity Crowdfunding
- Italy, France, United Kingdom
Portfolio highlights
- Homepal — Homepal, a digital real estate agency, allows owners and buyers to make direct contact and independently organize visits to the house. It is also a site to buy, sell, and rent a house with the full support of a real estate agency, at low costs. The team of the Homepal RE real estate agency will then help in managing the negotiations and thecontracts.It was founded in 2015 and is headquartered in Italy.
- HiNelson — HiNelson an Italian-based online store for nautical accessories. HiNelson is the first nautical online store about high-level boating components. They select the best and successful brands in the nautical worldwide market, such as Veleria San Giorgio to guarantee maritime safety with their life jackets, moving through Polyform’s boat fenders foryacht protection, or the best anchoring and docking system by Lofrans’, Max Power and Quick and finishing with the most famous Plastimo’s compasses or and Bartomarine sail’s accessories.
- Yobs — Record your interviews, accelerate candidate review, coach recruiters and build a fair and rigorous hiring process.
Tim Dempsey is a Managing Partner at Epiphany Capital. He graduated from the University of Manchester.
Show more
Investment focus
- Software, SaaS, Information Technology
- Seed, Series A, Funding Round
- United Kingdom
Portfolio highlights
- Lunio — Say goodbye to wasted ad spend and false conversions. Use Lunio to stave off click fraud and invalid users, safeguarding the quality of your traffic and driving better returns from paid media
- Mitra bio — We are transforming skin-care by approaching ageing as a disease to be fought. We are developing a genetic and epigenetic discovery platform to help skincare companies find and develop new compounds that actually fight the root cause of skin ageing.
- PPC Protect — Say goodbye to wasted ad spend and false conversions. Use Lunio to stave off click fraud and invalid users, safeguarding the quality of your traffic and driving better returns from paid media
Entrepreneur, Investor
Show more
Investment focus
- Blockchain, Information Technology, Financial Services
- Seed, Pre-Seed, Series A
- France, United States, Cayman Islands
Portfolio highlights
- Keplr — Introducing the first, and leading, IBC-enabled wallet for Cosmos and beyond
- Reppo Labs — Blockchain Network that connect Data Owners with AI Developers and AI agents through Programmable IP Co-ownership
- Prodia — Prodia is a multimedia design software and developer of artificial intelligence that creates APIs and images.
Raphaël Varane is a French professional footballer who plays as a centre-back for Premier League club Manchester United and the France national team.
Show more
Investment focus
- Sports, Apps, Soccer
- Seed, Funding Round
- France, Portugal, United Kingdom
Portfolio highlights
- Kinvent — KINVENT is actively involved in the fields of physical rehabilitation and sports biomechanics producing innovative measuring and training devices for the facilitation of every day and athletic movements. Our strengths at KINVENT is that we can think and produce solutions to any challenge of sports biomechanics and physical rehabilitation.Triangular force plates for visual feedback balance training, sensors for continuous 3D kinematic analysis in the water, force sensors for kite surf, accelerometers for rowing and sailing, are some of our on demand products. If you are looking for excellence in hardware and software solutions for your work... work with us.Our KFORCE solution is a range of torque measuring instruments for human strength, balance and motion. This system consists of six instruments with high-precision measuring equipment, which concentrate all the know-how of K-INVENT. The display of the data recorded by the device sensors is transcribed by the KFORCE software, installed on any iOS or Android terminal. This accessory capable of reading and re-transcribing the information given by all dynamometers of the entire range is usable on smartphones or tablets with Android and IOS operating system
- ScorePlay — ScorePlay is an AI-powered media asset manager dedicated to sports. The MAM centralizes assets in a single media workspace, with AI-tagging. Distribute to athletes and sponsors automatically through app. Amplify your brand.
- Docent — Docent is the first AI-powered mobile application to offer a fully-personalized experience for discovering, accessing and collecting contemporary masterpieces.
Giampaolo’s aim has always been to apply a disruptive approach to functional food ingredients and that’s how he founded Italiana Ingredienti in ’89 and Campus in ’05. Both companies have been acquired, Italiana Ingredienti by Chr. Hansen in ‘99 and Campus by Firmenich in ’18. Today he serves as Founder and Chairman at Hi-Food, an Italian companyproviding key functional ingredients to food companies, and as a business Angel Investor in several startups.
Show more
Investment focus
- Biotechnology, Food and Beverage, Plant-Based Foods
- Seed, Pre-Seed
- Italy, Denmark
Portfolio highlights
- Chromologics — Chromologics produce natural sustainable colors. Our flagship product is ChromoRed which performs better than existing natural, red colorants. ChromoRed is also applicable with vegan, kosher and halal diets.
- Dreamfarm — We are a team of food-lovers 100% made in Italy! We dreamt of a better, tastier, more sustainable future and decided to join forces to create something special.
Alexandre Yazdi - Co-Founder and CEO @ Voodoo
Show more
Investment focus
- Software, Real Estate, Residential
- Seed, Pre-Seed, Funding Round
- France, Turkey, Portugal
Portfolio highlights
- ScorePlay — ScorePlay is an AI-powered media asset manager dedicated to sports. The MAM centralizes assets in a single media workspace, with AI-tagging. Distribute to athletes and sponsors automatically through app. Amplify your brand.
- Zamp — We take care of sales tax, so you don't have to.
- Sekai Studio — Creating mind blowing official entertainment anime fans have been dreaming about
Paul Forster
Show more
Investment focus
- Software, FinTech, Financial Services
- Seed, Series A, Pre-Seed
- United Kingdom, Germany, United States
Portfolio highlights
- Stackfix — Stackfix - We combine deep software and AI knowledge. We apply it to your business. We deliver returns.
- Singulate — The early Hopin team (#1, #4, #30 are cofounders) are back together to solve the biggest problem they saw in events and marketing at Hopin. They’re building a next gen AI marketing platform called Singulate. Singulate provides the easiest way to do audience segmentation and better relevance-personalization for marketing to individuals at scale —results of up to 10X higher CTRs and 5X response rates. They’re helping marketers (in demand gen, growth, community/events) nurture and convert more pipeline from their events and existing customers - it’s not an AI cold outreach sales tool (although it can do reactivations) but rather a lifecycle growth marketing tool. The best personalization is invisible - this is the future of large-scale communication. Get a demo to see the product.
- Purple Dot — Sell More by Selling Earlier
Nadav Ben-Chanoch
Show more
Investment focus
- Software, Information Technology, Health Care
- Seed, Pre-Seed, Funding Round
- United States, United Kingdom, France
Portfolio highlights
- micro1 — We help companies hire and manage the best software engineers easily.
- TRIVER — Triver develops online and digital tools to assist and support various financial services. It is based in London, England.
- Skedway — The optimization hub for the Modern Enterprise - Visualize, integrate and manage every shared company asset in one place.
Dr. André-Jacques Auberton-Hervé co-founded Soitec with Jean-Michel Lamure in 1992. As President, CEO and Chairman of the Board, Auberton-Hervé is responsible for overseeing the strategic, operational and financial activities of the company.Prior to founding Soitec, Auberton-Hervé managed several joint development programs between Leti andThomson-CSF, which focused on the technological transfer from R&D to production applications. These programs included the transfer of 1.2 µm and 0.8 µm SOI CMOS for space applications. He was also in charge of several projects, which applied SOI to 3D integration, VLSI and ULSI.In July of 2005, Auberton-Hervé was elected to serve as the European representative to SEMI’s International Board of Directors. His demonstrated vision, experience and leadership capabilities within the industry contributed to his appointment to the board. Auberton-Hervé is also the recipient of the 1999 European SEMI Award in recognition of his work on Smart Cut™ technology and his overall contributions to the semiconductor industry as a whole. Auberton-Hervé is a member of the Electrochemical Society and the IEEE.
Show more
Investment focus
- Medical, Biotechnology
- Seed, Series A
- France
Portfolio highlights
- LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and
Prof. Riesner has held the Chair of Biophysics at the Heinrich-Heine-University in Düsseldorf, Germany since 1980 and is Director of Technology at the University of Düsseldorf. He received his Ph.D. from the University of Braunschweig, Germany. Prof. Riesner is also a member of the Supervisory Board and a Director of Qiagen N.V., Netherlands.
Show more
Investment focus
- Biotechnology, Pharmaceutical, Health Care
- Seed
- Germany
Portfolio highlights
- Numaferm — NUMAFERM challenges this paradigm. We have developed a reliable, cost-efficient manufacturing process that enables the reduction of production costs dramatically (up to 1000x). How is it possible? Our process is based on a well-designed microorganism that converts simple nutrients to peptides. It is the first-in-place bioprocess that serves as areliable platform for the production of peptides; independent of their sequence, length or functionality.
- Pantherna Therapeutics — We develop advanced lipid nanoparticles (LNP) technologies for non-hepatic, organ- and cell-selective delivery of mRNA-based therapeutics.
Thor Bjorgolfsson - Entrepreneur, Businessman and Adventure Capitalist Thor Bjorgolfsson, Iceland’s first and only current billionaire, is an investor and business innovator who is not afraid of risk. He has been an entrepreneur since childhood, making his first deal at the age of 10, when he purchased a stack of vintage Marvel comics withborrowed money.In 2004, he founded Novator Partners, an alternative investment firm. He has strategically developed the company to allow it to maintain maximum flexibility as well as to facilitate investments in both strategic (buy and hold) and financial (buy and exit) opportunities.With Novator, Thor leverages private equity as well as macro investments and manages assets across a variety of sectors and geographic locations. He is an active investor in emerging economies including Central and Eastern Europe as well as Latin America.Novator Partners has been a major player in telecom businesses. Thor is a stakeholder in a Polish telecom company called Play, which went public in 2017. In addition, he holds shares in WOM, a Chilean telecommunications firm.Bjorgolfsson’s first fortune was made in post-soviet Russia. At a time when others perceived Russia to be tumultuous, he saw an underserved market that presented an exciting opportunity to invest in great ideas and businesses. He co-founded and developed Bravo Brewery, which produced beer and alcopops. Bravo became one of Russia’s premier brewing companies, particularly through its popular Botchkarov beer brand. Thor sold the business in 2002 to Heineken for $100 million.With the sale of Bravo, he was able to diversify his holdings by reinvesting in new ventures, focusing on telecommunications, pharmaceuticals, and banks. In a few years, he was able to turn that $100 million into a net worth of over $2.1 billion.A year after being featured on the 2007 cover of Forbes Magazine, Iceland went nearly bankrupt overnight and Thor found himself at the epicenter of the financial crisis. As a major shareholder in Landsbanki with personal guarantees of 350m euro, he refused to declare bankruptcy and eventually succeeded in paying off all of it. He then went on to invest in new businesses, re-establishing himself and being featured on the Forbes list of billionaires once again.During this time of rejuvenation, he wrote Billions to Bust and Back: How I Made, Lost and Rebuilt a Fortune, And What I Learned on the Way (2014). In the book, he shares his perspective of what it was like to be at the center of the storm and how he made it back to financial success. He proposes that the greatest strength an entrepreneur can possess is a positive attitude.The 52-year-old Thor was educated in the United States where he earned a Bachelor of Science degree from New York University. In 2005, he was honored as a Young Global Leader by the World Economic Forum. In spite of his intense schedule, Thor enjoys sharing his experience and business insight, making him a sought-after speaker. A multilingual Icelandic citizen, Thor spends most of his time in London, living with his wife and three children. Thor's personal passion is his collection of six motorcycles, which he rides whenever time permits.
Show more
Investment focus
- Big Data, TV, TV Production
- Seed, Series A, Series C
- United Kingdom, Germany
Portfolio highlights
- Olvin — Olvin helps reactive real-world businesses get ahead of the curve and become proactive through the use of its AI powered, predictive analytics platform. Harnessing billions of real world data points, from events and precise location, through to weather and points of interest, Olvin's advanced neural network identifies patterns. Through theuse of both probabilistic and deterministic scoring, Olvin's AI provides actionable insights to brands, retailers and businesses to give them an unparalleled opportunity to delight their customers, identify opportunities and get ahead of potential threats.
- DNEG — We are DNEG, one of the world's leading visual effects and animation studios for feature film and television, honoured with the Academy Award six times
- atai Life Sciences — We are a clinical-stage biopharmaceutical company developing new mental health treatments to transform patient outcomes.
Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.
Show more
Investment focus
- Biotechnology, Food and Beverage, Health Care
- Series A, Seed, Funding Round
- United States, United Kingdom, Germany
Portfolio highlights
- Voxia — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
- Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
- The Duppy Share — The Duppy Share Caribbean Rum is the best rum for cocktails, mixed drinks and rum gifts. Try all our rum recipes, from rum and ginger to dark rum punch.
Luc Vauterin - Board Member @ ONTOFORCE
Show more
Investment focus
- Life Science, Data Integration, Data Visualization
- Seed, Series A
- Belgium
Portfolio highlights
- ONTOFORCE — ONTOFORCE creates and implements pioneering semantic search technology for information management. Our user-friendly data search platform DISQOVER builds uniquely intelligent links between heterogeneous data sources, allowing everybody to become a data scientist.
Chris Mairs - Venture Partner @ Entrepreneur First
Show more
Investment focus
- Software, Financial Services, FinTech
- Seed, Pre-Seed, Angel
- United Kingdom, United States
Portfolio highlights
- VitVio — VitVio is a platform built around AI and computer vision with the goal of improving efficiency and quality of care in operating rooms.
- Quantly — LLM-enabled financial research at the speed of thought.
- Borderless — Borderless is a workforce migration platform.It offers automation solutions that focuses on all aspects of hiring and onboarding of foreign workers, including recruitment, immigration, relocation, and compliance.
Sauli Törmälä is the Board Member, CFO at Promilless Oy. He attended University of Oulu.
Show more
Investment focus
- Life Science, Biotechnology
- Seed
- Finland
Portfolio highlights
- Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Mark is currently a Founding Partner and LP and Investment Committee member at Kindred Capital, a European Seed-Stage Venture fund, based in London. He was a General Partner at Balderton Capital/ Benchmark Europe from 2002 through 2015, and an EIR at Benchmark Capital in 1999/2000.He spent the prior 15 years @ Goldman Sachs, where hewas a General Partner and Management Committee member. He studied Economics at both University of Oxford and Queen's University in Canada.
Show more
Investment focus
- Software, E-Commerce, Health Care
- Series A, Seed, Funding Round
- United Kingdom, United States, The Netherlands
Portfolio highlights
- ONI — Where are you in your super-resolution journey? ONI is here to support you along your super-resolution journey Answer a few simple questions to discover key resources that can help you make the most of single-molecule imaging technology across a wide range of applications Products Gallery FAQs Subscribe to our mailing list
- Ufonia — Ufonia is replacing routine patient healthcare interactions with next-generation automated phone calls.
- Arctoris — Arctoris is a platform company headquartered in Oxford, with its US operations based in Boston and its APAC operations based in Singapore. Arctoris developed and operates a unique drug discovery platform powered by advanced robotics and data science combined with an experienced team of biotech & pharma veterans. Arctoris actively pursuesseveral drug discovery programs in oncology and neuro, while also providing access to its platform to select biotech and pharma partners. Arctoris' approach of data-driven drug discovery leads to higher chance of success, and an accelerated progression of programs towards the clinic.
Jan Hruska
Show more
Investment focus
- Medical, Health Care, Life Science
- Seed, Funding Round
- United Kingdom
Portfolio highlights
- Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Xavier Niel is the Co-Founder and CEO of NJJ Capital. He previously worked at Worldnet as a Founder. Xavier Niel attended Saint Michel de Picpus Catholic private high school.
Show more
Investment focus
- Artificial Intelligence, Software, SaaS
- Seed, Pre-Seed, Series A
- France, United States, Ecuador
Portfolio highlights
- Pixmania — Pixmania is an e-commerce website that provides buying and selling of speakers, cameras, headphones, and mobile devices.
- Genesis AI — Genesis AI operates as a physical AI lab and full-stack robotics company.
- Mobile Club — Mobile.club is a smartphone rental without obligation.
Vishal Gulati: Vishal serves as a venture partner specialising in digital health at DFJ Esprit, Europe's leading Silicon Valley style venture capital firm with over $1b under management. Since 2012, Vishal has been Europe’s leading promoter of investment into the emerging digital health sector and chairman of Digital Health Forum, whichsupports the best in class digital health companies to grow into global enterprises. Vishal serves on several boards including Horizon Discovery Group PLC (Cambridge, UK), a gene editing company; Fluidics Analytics (Cambridge, UK), a next gen protein discovery engine, Frameshift a healthcare information flow platform (London, UK) and EcoEos (San Francisco, USA), a consumer genomics business. His previous investments include Napo Pharmaceuticals, Glenmark, Renovo and Phagenesis.
Show more
Investment focus
- Biotechnology, Biopharma, Life Science
- Seed, Series A, Series B
- United Kingdom, Hungary
Portfolio highlights
- Arctoris — Arctoris is a platform company headquartered in Oxford, with its US operations based in Boston and its APAC operations based in Singapore. Arctoris developed and operates a unique drug discovery platform powered by advanced robotics and data science combined with an experienced team of biotech & pharma veterans. Arctoris actively pursuesseveral drug discovery programs in oncology and neuro, while also providing access to its platform to select biotech and pharma partners. Arctoris' approach of data-driven drug discovery leads to higher chance of success, and an accelerated progression of programs towards the clinic.
- evonetix — Spearheading a radical new approach to gene synthesis to improve access to high-quality, gene-length DNA. Redefine possible.
- Turbine — Turbine builds a platform to understand the inner mechanisms of cancer, enabling the discovery of novel protein targets, precision biomarkers, and better translation to patients. Turbine uses its proprietary Simulated Cell technology in combination with Artificial Intelligence to build a faster and deeper biological understanding of therapeutictargets or indications, untangling the complexity of cancer.
Xavier Niel is based out of Paris, Ile-de-France and is the Co-Founder and CEO of NJJ Capital. Xavier previously worked at Worldnet as a Founder. Xavier Niel attended Saint Michel de Picpus Catholic private high school.
Show more
Investment focus
- Software, Artificial Intelligence, SaaS
- Seed, Series A, Funding Round
- France, United States, United Kingdom
Portfolio highlights
- Pixmania — Pixmania is an e-commerce website that provides buying and selling of speakers, cameras, headphones, and mobile devices.
- Genesis AI — Genesis AI operates as a physical AI lab and full-stack robotics company.
- Mobile Club — Mobile.club is a smartphone rental without obligation.
Mr. Linton is the founder of Canopy Growth Corporation (CGC) and co-founder of Tweed Marijuana Inc.Bruce’s primary focus has been to position cannabis brands in a competitive market and to raise the capital necessary to fund such operations. Bruce’s experience as a founder, CEO, and Board member across a wide variety of enterprises has influencedthe positive start of Canopy Growth, which to date has enjoyed market support for capital raises of over $150 million and the distinction of being the first company in the industry to be offered debt instruments by a federal lender. Bruce has led three M&A transactions valued over $500 million total since founding CGC. In addition to his leadership responsibility at Canopy Growth, Bruce is the CEO of communications company Martello Technologies. After beginning his career at Newbridge Networks Corporation, he has since held positions that include General Manager and Re-Founder of Computerland.ca, President and Co-Founder of webHancer Corp, and part of the establishing team at CrossKeys Systems Corporation. He was also part of the leadership team for the NASDAQ/TSX initial public offering at CrossKeys. Bruce has been responsible for the acquisition and/or disposition of over $600 million in business assets, and has established regular engagement with the World Bank and Asia Development Bank while focused on markets in India, Philippines, China, Peru, Colombia, Ecuador, Azerbaijan and Uzbekistan. He is the past Chairman of the Ottawa Community Loan Foundation, past Board Member and Treasurer of Canada World Youth past Board of Governor for Carleton University, past President of the Nepean Skating Club and past President of the Carleton University Students Association.
Show more
Investment focus
- Health Care, Cannabis, Biotechnology
- Seed, Post-IPO Equity, Pre-Seed
- Canada, United States, Denmark
Portfolio highlights
- Omura — Discover heat-not-burn technology with Omura's dry herb vaporizer devices. Explore sustainable vaping options for hemp & whole flower CBD.
- Octarine Bio — Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration. Inspired by nature, to protect nature.
- Martello Technologies — Prioritize and resolve performance problems and optimize the Microsoft 365 and Teams user experience with Martello Vantage DX.
Hugh Grant is President and Chief Executive Officer at Monsanto.
Show more
Investment focus
- Biotechnology, Machine Learning
- Seed, Funding Round
- United Kingdom
Portfolio highlights
- Bactobio — At Bactobio, our mission is to create a safer and greener world by harvesting valuable metabolites from biological dark matter.
Albert Wenger is a managing partner at Union Square Ventures. Before joining USV, Albert was the president of del.icio.us through the company’s sale to Yahoo and an angel investor (Etsy, Tumblr). He previously founded or co-founded several companies, including a management consulting firm and an early hosted data analytics company. Albert graduatedfrom Harvard College in economics and computer science and holds a Ph.D. in Information Technology from MIT.
Show more
Investment focus
- Software, Analytics, Manufacturing
- Series A, Series B, Seed
- United States, Germany, Egypt
Portfolio highlights
- Brale — Combining the best of CeFi & DeFi.
- Terra.do — Learn about climate change and start working on climate change solutions today with the Terra.do community.
- Unearthly Materials — Unearthly Materials is a transformative materials company focused on delivering practical room-temperature superconductors and powering the century of superconductivity.
Sten Tamkivi is the Chief Product Officer at Topia (formerly MOVE Guides). He was previously co-founder and CEO of Teleport (acquired by Topia), the place to scout for startup people. He co-founded the company as an EIR at Andreessen Horowitz.Sten has been a tech entrepreneur since 1996. After founding a few companies in Estonia, he joined Skypeas an early executive, ran the original R&D office, and held several global product leadership roles for 8+ years.He has an MS in Management from Stanford GSB.
Show more
Investment focus
- Software, Financial Services, Artificial Intelligence
- Seed, Pre-Seed, Series A
- Estonia, United States, United Kingdom
Portfolio highlights
- Salv — Smart AML solutions. Detect and mitigate money laundering risks through advanced transaction monitoring, sanction screening, and KYC risk scoring.
- Katana — Katana gives thousands of manufacturers a live look at their business with visual, intuitive, and easy-to-use ERP software.
- Entrepreneur First — We are the best place for the world's most ambitious talent to come together and build game-changing technology startups from scratch.
Investors by industry
Google
Marketplace
Hardware
Energy
Proptech
Health Care
Biotech
Artificial intelligence
Climate
Consumer
Community
Impact
Gaming
FinTech
EdTech
Sustainability
Venture Capital
Big Data
Web3
B2B
Financial Services
Finance
Infrastructure
Education
Photography
Payments
Food and Beverage
Video Games
Organic Food
Retail
Beauty
Publishing
Clean Energy
Real Estate
Manufacturing
Art
Music
Android
Internet
Enterprise Software
eSports
Franchise
Sports
Construction
Digital Media
Email
Medical
Social Network
Wellness
Social Media
Mobile
Legal
Local
Recruiting
Cannabis
Platforms
Fitness
Travel
Mobile Advertising
Biotechnology
Hospitality
Social
Automotive
Crowdfunding
Wine And Spirits
Medical Device
CleanTech
Transportation
Mobile Apps
InsurTech
Enterprise
LGBT
Fashion
Oil and Gas
Life Science
Theatre
Film
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Social Impact
Software
Celebrity
Cryptocurrency
Machine Learning
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
United Kingdom
Canada
South Korea
Ireland
United States
New Zealand
India
Germany
Australia
Armenia
South Africa
Spain
Japan
Africa
China
Sri Lanka
Singapore
Qatar
Asia
Indonesia
Vietnam
Oceania
LATAM
Middle East
Europe
Saudi Arabia
Brazil
Bulgaria
Belize
Bahrain
Croatia
Georgia
Belarus
Hungary
France
Ghana
Ethiopia
Gibraltar
Chile
Egypt
Finland
Costa Rica
Greece
Barbados
Belgium
Estonia
Bermuda
Czech Republic
Denmark
Algeria
Liechtenstein
Hong Kong
Liberia
Lebanon
Mauritius
Ecuador
Peru
Faroe Islands
Sierra Leone
El Salvador
Norway
Uganda
Israel
Venezuela
Malaysia
Sweden
Mexico
Slovenia
Nicaragua
Poland
Jersey
Panama
Uruguay
Morocco
Mali
Lithuania
Ukraine
Italy
Tajikistan
Philippines
Puerto Rico
Kuwait
Portugal
Malta
Myanmar
Dominican Republic
Tunisia
Azerbaijan
Iceland
Taiwan
Nigeria
Bahamas
Namibia
Tanzania
Iraq
Turkey
United Arab Emirates
Jamaica
San Marino
Senegal
Honduras
Togo
Uzbekistan
Isle of Man
Serbia
Bolivia
Russian Federation
Luxembourg
Zambia
Rwanda
Zimbabwe
Thailand
Pakistan
Grenada
Albania
Jordan
Romania
Bangladesh
Argentina
Kazakhstan
Cayman Islands
Kenya
Cambodia
Oman
Latvia
Cyprus
Austria
Switzerland
Cameroon
Colombia
Marshall Islands
Guatemala
Seychelles
Angel Investors in Europe by industry
Crowdfunding
Venture Capital
Restaurants
Film
Social
Web3
Education
Financial Services
Photography
Cryptocurrency
Finance
Food and Beverage
Wine And Spirits
Medical
Medical Device
Email
Sporting Goods
Social Media
Manufacturing
Digital Media
Art
Music
Mobile
Android
Blockchain
Local
Social Network
Legal
Social Impact
Construction
Software
Sports
Enterprise Software
eSports
Fitness
Automotive
CleanTech
Travel
InsurTech
Mobile Advertising
Platforms
Cannabis
Biotechnology
FinTech
Enterprise
Health Care
Consumer
Video Games
Biotech
Energy
EdTech
Sustainability
Climate
SaaS
Proptech
Marketplace
Community
Hardware
Transportation
Real Estate
Retail
Mobile Apps
Infrastructure
Beauty
Fashion
B2B
Publishing
Big Data
Clean Energy
Oil and Gas
Renewable Energy
Wellness
Impact
Life Science
Recruiting
Internet
Franchise
Gaming
Non Profit
Agriculture (agtech)
Media (entertainment)
Machine Learning
Payments
Organic Food
Hospitality
Artificial intelligence